Abbott Laboratories (ABT)
$102.97+0.35%Close
SELLRECOVERY · day 4
Key stats
Short interest · FINRA settlement 2026-09-30
52-week IV14.6%–53.0%
- Market cap
- $179.4B
- Beta
- 0.58
- Div yield
- 3.02%
- P/E (TTM)
- 33.11
- IV-%ile
- 87
- IV ATM
- 34.7%
- Short % float
- 0.79%
- Days to cover
- 1.5
- SI change
- -31.5%
- 1W
- +4.29%
- 1M
- +0.92%
- vs SPY 1W
- +4.43%
- vs SPY 1M
- -1.58%
Industry peers
FMP comparable companies · ranked by market cap
- JNJSELLJohnson & Johnson$618.1BBEARQ 22$256.48+2.13%
- TMOBUYThermo Fisher Scientific Inc.$241.1BBULLQ 18$651.98+1.53%
- DHRBUYDanaher Corporation$152.9BRECOVERYQ 36$217.46+0.83%
- MDTBUYMedtronic Plc$112.3BRECOVERYQ 14$87.75+1.31%
- SYKBUYStryker Corporation$106.2BRECOVERYQ 25$276.97-0.33%
- BSXSELLBoston Scientific Corporation$62.5BRECOVERYQ 6$42.04-0.72%
- BDXBUYBecton, Dickinson and Company$50.4BBULLQ 21$182.75+0.81%
- EWSELLEdwards Lifesciences Corporation$48.5BBEARQ 18$84.24+1.38%
- GEHCBUYGE HealthCare Technologies Inc.$29.0BRECOVERYQ 7$64.22-0.47%
- SMMNYSiemens Healthineers AG$24.2B$21.64
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on ABT?
- LOPJLB’s latest quantitative signal on Abbott Laboratories (ABT) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is ABT in?
- Abbott Laboratories (ABT) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Abbott Laboratories (ABT) do?
- Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmac…